Terra Tech Corp (OTCMKTS:TRTC) an agriculture company focused on cannabis recently announced that it has received two permits for opening cannabis dispensaries in California. The City of Santa Ana granted the permission to the company to operate two retail dispensaries, one on the Carnegie Avenue and the other on Dyer Road in Santa Ana.
Terra Tech eyeing expansion in Southern California
Terra Tech’s CEO, Derek Peterson stated,” We first entered the Southern California market in September of last year when we commenced operating and managing a cannabis dispensary in Santa Ana. We are proud to have successfully leveraged this first mover advantage to obtain two new retail permits and expand our presence in Orange County.” Terra Tech has plans to convert its first retail dispensary spread across 44,000 square foot on the Dyer Road into a completely vertical cannabis complex. Terra Tech purchased the facility at the start of the year with the view to expand its presence in and around Southern California.
Now that the company has received the permit, it will utilize this opportunity for acquiring permits from the City of Santa Ana for cultivating, manufacturing and distributing cannabis on the site. Terra Tech intends to develop this property on Dyer Road. Apart from operating as a retail dispensary, the company also is planning to increase its size beyond 50,000 square feet so that it can be transformed into a cannabis complex.
The site will also dedicate a small space to event facility so that cannabis theme-based events including movie nights and concerts could be hosted on a large scale. The Dyer Road site is in the neighborhood of 55 Freeway and has a direct entry route to the marketplace of Southern California. It will help Terra Tech to reach the area with heavy traffic and high population density easily.
Terra Tech secures 25% stake in The Healing Tree Collective
The Irvine, California-based company recently announced that it has secured 25% stake in a marijuana dispensary operator, The Healing Tree Collective Inc. It should be noted that this company based in California received a retail permit for its facility near the City of Santa Ana. Since Terra Tech is aiming to expand in the Southern California region, this new development can surely contribute towards making the company’s aspirations come true.
Vapor Group Inc (OTCMKTS:VPOR) Business Model Paying Off As Orders for Isolate CBD Stream In
Vapor Group Inc (OTCMKTS:VPOR) is evidently having a spectacular run following the adoption of a new business model early this year focused on the lucrative CBD industry estimated to be worth well over $16 billion. The company recently secured $80,000 order for its premium CBD isolate bringing the total tally of orders to $600,000 this year alone.
$500,000 in under 3 months
As of April this year, the company had reportedly secured orders totaling about $500,000. In its Q1 2019 earnings, VPOR reported a number of high-profile business deals from reputable names in the industry including White Label liquid and GenCanna global, Inc among others. The company’s biggest purchase order thus far came in May when industry titan, Diamond CBD owned by potNetwork holdings placed a hefty $210,000 order for its bulk CBD isolate.
Vapor bills itself as the provider of industry grade CBD isolate famed for its high potency and purity. The product is developed in the company’s state-of-art manufacturing facilities that utilize sophisticated nanotechnology to deliver a premium end product sought after by industry leaders. The trickling enormous purchase orders are testimony of the product’s unparalleled effectiveness.
The company’s products are manufactured from 100% organic hemp sourced from the best growers in the United States from the states of Colorado, Kentucky, and Oregon. VPOR is constantly researching and experimenting on new processing methods and techniques to stay at par with the industry’s dynamic trends.
VPOR’s President and CEO, David Zinger is confident that the company is on course to becoming the premium suppliers of industry-level CBD isolate. Zinger credits the company’s success to over the past few months to “smart planning and strategizing.” Further, he is optimistic that with the continued sustainable growth, the will be able to provide long-term value to their stakeholders.
Positive trends witnessed in the CBD industry points to a lucrative future for players in the sector including Vapor. Reportedly, 7% of Americans are using CBD products now with the number expected to spike by 10% come 2025.
Medical Marijuana Inc. (OTCMKTS:MJNA) Authorized To Offer CBD Products In Bulgaria
Medical Marijuana Inc. (OTCMKTS:MJNA) has announced that it has been granted authorization to sell its hemp derived CBD products in Bulgaria.
Medical Marijuana receives authorization for CBD products in Bulgaria
Blake Schroeder the CEO of Kannaway stated that they are delighted to continue paving the way for CBD acceptance in Bulgaria to follow suit with what is happening in the rest of the world. The CEO added that following the authorization they were hoping to position themselves in the Bulgarian market and become leaders in CBD education across Europe.
The authorization means that Kannaway’s goods will be freely sold in Bulgaria and they are equally approved for export. Kannaway VP Alex Grapov said that the company was looking forward to trailblazing the global CBD market as advocates of its benefits. He added that they have met with regulatory bodies to makes sure that the company’s operations are within the purview of the law thus creating an avenue for customers and brand ambassadors.
Publication of CBD research on CIPN in Molecular Sciences Journal
Last week Medical Marijuana announced that its portfolio company Kannalife Inc. (OTCMKTS: KLFE) had published its findings on Chemotherapy-Induced Peripheral Neuropathy in the Molecular Neuroscience Journal. Market Study Report LLC has indicated that the international market for CIPN treatment is expected to exceed $1.88 billion by 2024. Kannalife expects clinical trials for its CBD-like molecule KLS-13019 as a therapeutic treatment for CIPN to commence in the second quarter of 2020.
Medical Marijuana CEO Stuart Titus said that CIPN affects around 30% to 405 of patients undergoing chemotherapy adding that they were pleased to support Kannalife in its research to discover a treatment alternative for such patients.
Kannalife was funded by the National Institute on Drug Abuse to work on the research. The grant permits the research in the development of KLS-13019 in CIPN and drug dependence. Kannalife has the obligation to study important advancements that involve identification of the mechanisms that bring CIPN and the application o0f study results in designing on novel treatment approaches for neuropathic pain and use of the approaches in reducing opioid prescription and opioid abuse.
Generex Biotechnology Corporation (OTCMKTS:GNBT) Launches An Integrated Health Management Platform
In a new wake of events, Generex Biotechnology Corporation (OTCMKTS:GNBT) has introduced a platform, which primarily deals with in-depth patient health management services. NuGenerex Medical Marketing (NMM) is a significant project and will act as the company’s sales and marketing backbone support. Some of the areas it will handle include patient identification, acquisition, and onboarding. Its establishment comes at a time when hundreds of pharmaceuticals businesses are seeking measures to accelerate their growth and expansion.
Generex is seeking entry into the U.S market and the reason it has embraced a multi-channel acquisition strategy. The strategy has been running for several months the main target being assets and organizations, which offer a series of services.
NMM will provide national marketing and customer service capabilities
Generex will benefit in a million ways from the new establishment; thanks to its capabilities. NMM plans to roll out an extensive pharmacy backbone, which will in return offer a nationwide footprint. It will have an integration with Customer Relationship Management (CRM) dashboard for Generex. Through a dedicated call-center, the integration will support the company’s ongoing patient support services and particularly the chronic care management.
In addition, NMM will offer compliant direct-to-patient outreach services, which are fully compliant with the market needs. An accomplished team, which has deep experience in pharmaceutical and medical device sales will support the new move. The team is trained in HIPAA, FTC and it has full exposure of the FDA rules. Thus it will ensure adherence to processes and procedures in the delivery of medical services.
The realization of a vision for a new healthcare enterprise
For the last two years, Generex has worked diligently to enhance the delivery of its services. Its emphasis is on unlocking new platforms, which will offer end-to-end treatment and services solutions. This far, the company is happy with its achievements according to the Chief Executive Officer Joseph Moscato.
He says, “We are delighted to launch NuGenerex Medical Marketing as another step in our overall corporate strategy to provide end-to-end solutions that optimize patient health outcomes.”
Meanwhile, the company has vowed to continue closing on the acquisition of additional operating assets. Its expectation is to meet the initial listing requirements one of them being a lucrative enterprise with a presence in another 23 states.
Zogenix, Inc. (NASDAQ:ZGNX) Fails To Produce Impressive Reductions In Seizures With Its Clinical Trial Drug Fintepla
Project 7 Group LLC of U.S.A Agrees To Sell And Promote CBD And CBG Enriched Hemp Seeds Of Maple Leaf Green World Inc (OTCMKTS:MGWFF)
Neutra Corp (OTCMKTS:NTRR) Aims To Become A Vertically Integrated Producer And Distributor Of Hemp Derived CBD Health Products With Fresh Private Equity
AeroGrow Manufacturing, A Subsidiary Of Grow Solutions Holdings Inc (OTCMKTS:GRSO), Hires EngComp Services To Provide Certified Construction Documents For $1.5 Million PO
American Green Inc (OTCMKTS:ERBB) Begins Online Sales Of High Quality CBD Infused One HD Seltzer Water in 12 Oz Cans
MedMen Enterprises (OTCMKTS:MMNFF) CEO Adam Bierman Step Down And Relinquishes Super Voting Shares
Kannaway, A Subsidiary Of Medical Marijuana Inc (OTCMKTS:MJNA), Is The Most Popular CBD MLM Company: Hemp Meds Mexico Inaugurates a New Office In Mexico
Medmen Enterprises Inc (OTCMKTS:MMNFF) Collaborates With Kikoko, Barkley, And Papa To Promote Its Cannabis Products
Elev8 Brands (OTCMKTS:VATE) Partners With Linda Bos To Promote The Use Of CBD Infused Creams And Beverages To Improve Health Of Athletes
Tetra Bio Pharma Inc (OTCMKTS:TBPMF) Issues An Update On The Tolerability, Safety, And Efficacy Of PPP003 Opthalmic Drug To Treat Eye Pain In Animals
Pharmacyte Biotech Inc (OTCMKTS:PMCB) Addresses Unmet Medical Needs Of Patients Suffering From LAPC: 57,600 People In The US Suffers From LAPC In 2020
Kannaway, A Subisidiary Of Medical Marijuana Inc (OTCMKTS:MJNA), Expands Into Kyrgyzstan, Kazakhstan, And Russia: Kannway Issues An Update On Newly Acquired Patents